NCT04164121View on ClinicalTrials.gov

A Clinical Study Trial of Phenlarmide in China

PHASE1CompletedINTERVENTIONAL
Enrollment

36

Participants

Timeline

Start Date

December 17, 2019

Primary Completion Date

December 2, 2020

Study Completion Date

December 2, 2020

Conditions
Parkinson Disease
Interventions
DRUG

Phenlarmide Tablets

Oral administration was conducted on an empty stomach, and the drug was administered once a day on day 1 and once a day from day 8 to day 17.

DRUG

Placebos

Oral administration was conducted on an empty stomach, and the drug was administered once a day on day 1 and once a day from day 8 to day 17.

Trial Locations (1)

100032

Peking union medical college hospital, Beijing

All Listed Sponsors
lead

Yiling Pharmaceutical Inc.

INDUSTRY

NCT04164121 - A Clinical Study Trial of Phenlarmide in China | Biotech Hunter | Biotech Hunter